237 related articles for article (PubMed ID: 22918549)
21. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and biological characteristics of male breast cancer in Italy.
Mangone L; Ferrari F; Mancuso P; Carrozzi G; Michiara M; Falcini F; Piffer S; Filiberti RA; Caldarella A; Vitale F; Tumino R; Brustolin A; Tagliabue G; Giorgi Rossi P; Ottini L
Breast Cancer; 2020 Jul; 27(4):724-731. PubMed ID: 32114665
[TBL] [Abstract][Full Text] [Related]
23. Risk of second breast cancer according to estrogen receptor status and family history.
Bouchardy C; Benhamou S; Fioretta G; Verkooijen HM; Chappuis PO; Neyroud-Caspar I; Castiglione M; Vinh-Hung V; Vlastos G; Rapiti E
Breast Cancer Res Treat; 2011 May; 127(1):233-41. PubMed ID: 20878464
[TBL] [Abstract][Full Text] [Related]
24. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
[TBL] [Abstract][Full Text] [Related]
25. Subsequent thoracic cancers among patients diagnosed with lung cancer: a SEER database analysis.
Abdel-Rahman O; Cheung WY
Curr Med Res Opin; 2017 Nov; 33(11):2009-2017. PubMed ID: 28532174
[TBL] [Abstract][Full Text] [Related]
26. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
[TBL] [Abstract][Full Text] [Related]
27. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
28. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
29. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.
Andersson M; Jensen MB; Engholm G; Henrik Storm H
Acta Oncol; 2008; 47(4):755-64. PubMed ID: 18465345
[TBL] [Abstract][Full Text] [Related]
30. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups.
Chu KC; Anderson WF
Breast Cancer Res Treat; 2002 Jun; 74(3):199-211. PubMed ID: 12206512
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992-2008.
Underwood JM; Rim SH; Fairley TL; Tai E; Stewart SL
Cancer Causes Control; 2012 Jul; 23(7):1009-16. PubMed ID: 22588679
[TBL] [Abstract][Full Text] [Related]
32. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
Nichols HB; Berrington de González A; Lacey JV; Rosenberg PS; Anderson WF
J Clin Oncol; 2011 Apr; 29(12):1564-9. PubMed ID: 21402610
[TBL] [Abstract][Full Text] [Related]
33. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
34. Histology-specific standardized incidence ratio improves the estimation of second primary lung cancer risk.
Eberl M; Tanaka LF; Kraywinkel K; Klug SJ
BMC Med; 2024 May; 22(1):187. PubMed ID: 38702684
[TBL] [Abstract][Full Text] [Related]
35. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.
Li CI; Daling JR; Porter PL; Tang MT; Malone KE
J Clin Oncol; 2009 Nov; 27(32):5312-8. PubMed ID: 19738113
[TBL] [Abstract][Full Text] [Related]
36. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
37. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
38. Long-term population-based risks of breast cancer after childhood cancer.
Reulen RC; Taylor AJ; Winter DL; Stiller CA; Frobisher C; Lancashire ER; McClanahan FM; Sugden EM; Hawkins MM;
Int J Cancer; 2008 Nov; 123(9):2156-63. PubMed ID: 18712734
[TBL] [Abstract][Full Text] [Related]
39. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
Li Z; Wang K; Shi Y; Zhang X; Wen J
Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
[TBL] [Abstract][Full Text] [Related]
40. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
